With sluggish pharmaceutical sales in the third quarter coming in below analysts’ expectations, Bayer is acutely aware of the challenges facing its key unit. | Despite the largely stagnant performance ...
Investing.com -- Bayer AG (ETR:BAYGN) on Wednesday reported a 138% jump in quarterly earnings, lifted by higher margins in ...
Bayer AG (($BAYRY)) announced an update on their ongoing clinical study. Bayer AG, in collaboration with Janssen Research & Development, LLC, has ...
The growth of the stronger product – which now accounts for more than a quarter of Eylea sales – allowed Bayer to predict ...
My husband was diagnosed with chronic lymphocytic leukemia (CLL) in 2010 and remained in stage 2 with no effects until 2022. In the interim, he was also diagnosed with atrial fibrillation and is ...
On May 12, 2025, President Trump signed an Executive Order titled: “Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients” directing the Administration to take numerous actions ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback